3D Medicines, Inc. (HK:1244) has released an update.
3D Medicines Inc. has announced that its next Board of Directors meeting is scheduled for August 30, 2024, where they will discuss the unaudited interim results for the first half of the year and consider issuing an interim dividend. This meeting will be crucial for investors as it may influence the company’s stock performance related to financial results and potential shareholder returns.
For further insights into HK:1244 stock, check out TipRanks’ Stock Analysis page.
